
Amber D. Steele
Examiner (ID: 11314, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1639, 1654, 1676, 1658 |
| Total Applications | 1278 |
| Issued Applications | 622 |
| Pending Applications | 159 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7225209
[patent_doc_number] => 20050255081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Stabilizers for hydrolyzable organic binders'
[patent_app_type] => utility
[patent_app_number] => 11/117088
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7569
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255081.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117088
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117088 | Stabilizers for hydrolyzable organic binders | Apr 27, 2005 | Abandoned |
Array
(
[id] => 4894067
[patent_doc_number] => 20080103166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Remedy For Psychoneurotic Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/587621
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3225
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103166.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587621 | Remedy for psychoneurotic diseases | Apr 27, 2005 | Issued |
Array
(
[id] => 5258776
[patent_doc_number] => 20070212408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Stable Pharmaceutical Composition Containing Benzimidazole Derivatives and Method of Manufacturing the Same'
[patent_app_type] => utility
[patent_app_number] => 11/587720
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3171
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587720
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587720 | Stable Pharmaceutical Composition Containing Benzimidazole Derivatives and Method of Manufacturing the Same | Apr 26, 2005 | Abandoned |
Array
(
[id] => 5141287
[patent_doc_number] => 20070003503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Tissue enhancement implant and method'
[patent_app_type] => utility
[patent_app_number] => 11/110282
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6707
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110282 | Tissue enhancement implant and method | Apr 19, 2005 | Abandoned |
Array
(
[id] => 5586134
[patent_doc_number] => 20090105336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Beneficial Effects of Increasing Local Blood Flow'
[patent_app_type] => utility
[patent_app_number] => 11/587328
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10817
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105336.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587328
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587328 | Beneficial Effects of Increasing Local Blood Flow | Apr 18, 2005 | Abandoned |
Array
(
[id] => 4792844
[patent_doc_number] => 20080293818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Regulator of Physiological Function of Ghrelin and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/628743
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14292
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293818.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628743
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628743 | Regulator of Physiological Function of Ghrelin and Use Thereof | Apr 18, 2005 | Abandoned |
Array
(
[id] => 10006867
[patent_doc_number] => 09050365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Transdermal delivery of beneficial substances effected by a hostile biophysical environment'
[patent_app_type] => utility
[patent_app_number] => 11/587323
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10787
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11587323
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587323 | Transdermal delivery of beneficial substances effected by a hostile biophysical environment | Apr 18, 2005 | Issued |
Array
(
[id] => 4682886
[patent_doc_number] => 20080249112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Mitotic Kinesin Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/547834
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19161
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249112.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547834
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547834 | Mitotic Kinesin Inhibitors | Apr 5, 2005 | Abandoned |
Array
(
[id] => 5225613
[patent_doc_number] => 20070254880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Heteroaryl Piperidine Glycine Transporter Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/593950
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21578
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593950 | Heteroaryl piperidine glycine transporter inhibitors | Mar 22, 2005 | Issued |
Array
(
[id] => 33688
[patent_doc_number] => 07786165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Aminophenylpropanoic acid derivative'
[patent_app_type] => utility
[patent_app_number] => 10/592789
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95868
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592789 | Aminophenylpropanoic acid derivative | Mar 13, 2005 | Issued |
Array
(
[id] => 4549144
[patent_doc_number] => 07960427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => '5-hydroxyindole-3-carboxylate derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/592619
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26494
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960427.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592619 | 5-hydroxyindole-3-carboxylate derivatives and uses thereof | Mar 10, 2005 | Issued |
Array
(
[id] => 7703046
[patent_doc_number] => 08088800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-03
[patent_title] => '4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 10/598281
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10973
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/088/08088800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598281 | 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity | Mar 8, 2005 | Issued |
Array
(
[id] => 4785000
[patent_doc_number] => 20080138329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Inhibitors of Dna Methylation in Tumor Cells'
[patent_app_type] => utility
[patent_app_number] => 10/591867
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10449
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138329.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591867 | Inhibitors of Dna Methylation in Tumor Cells | Mar 7, 2005 | Abandoned |
Array
(
[id] => 4720193
[patent_doc_number] => 20080242716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Ion Channel Modulators'
[patent_app_type] => utility
[patent_app_number] => 10/592216
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9360
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592216 | Ion Channel Modulators | Mar 6, 2005 | Abandoned |
Array
(
[id] => 4823269
[patent_doc_number] => 20080227787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Use of New Lipoxygenase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/590450
[patent_app_country] => US
[patent_app_date] => 2005-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22018
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590450
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590450 | Use of New Lipoxygenase Inhibitors | Mar 1, 2005 | Abandoned |
Array
(
[id] => 8533420
[patent_doc_number] => 08309574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Nuclear transfer promoter for Rac protein and method of screening the same'
[patent_app_type] => utility
[patent_app_number] => 10/590493
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 3140
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10590493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590493 | Nuclear transfer promoter for Rac protein and method of screening the same | Feb 23, 2005 | Issued |
Array
(
[id] => 5160415
[patent_doc_number] => 20070173459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Mixtures and methods for the induction of resistance in plants'
[patent_app_type] => utility
[patent_app_number] => 10/590281
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7327
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590281 | Mixtures and methods for the induction of resistance in plants | Feb 22, 2005 | Abandoned |
Array
(
[id] => 9245375
[patent_doc_number] => 08609656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Heteroarylphenylurea derivative'
[patent_app_type] => utility
[patent_app_number] => 10/590026
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69289
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10590026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590026 | Heteroarylphenylurea derivative | Feb 22, 2005 | Issued |
Array
(
[id] => 5101844
[patent_doc_number] => 20070185106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/598117
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25027
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185106.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598117 | Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists | Feb 16, 2005 | Abandoned |
Array
(
[id] => 5189119
[patent_doc_number] => 20070167428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Thienopyrroles as antagonists of gnrh'
[patent_app_type] => utility
[patent_app_number] => 10/598118
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22863
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598118 | Thienopyrroles as antagonists of gnrh | Feb 16, 2005 | Abandoned |